Avalo Therapeutics Inc. (AVTX) PT Raised to $10 at Cantor Fitzgerald

November 7, 2022 9:55 AM EST Send to a Friend
Cantor Fitzgerald analyst Louise Chen raised the price target on Avalo Therapeutics Inc. (NASDAQ: AVTX) to $10.00 (from $7.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login